Valuation: Danaher Corporation

Capitalization 115B 98.61B 90.16B 86.02B 158B 10,994B 160B 1,082B 419B 5,219B 430B 421B 18,183B P/E ratio 2026 *
25.7x
P/E ratio 2027 * 20.5x
Enterprise value 124B 106B 97.26B 92.8B 170B 11,860B 173B 1,167B 452B 5,630B 464B 454B 19,615B EV / Sales 2026 *
4.85x
EV / Sales 2027 * 4.43x
Free-Float
71.11%
Yield 2026 *
0.92%
Yield 2027 * 0.94%
1 day-1.60%
1 week-5.40%
Current month-9.52%
1 month-18.29%
3 months-23.84%
6 months-26.81%
Current year-29.27%
1 week 160.93
Extreme 160.93
171.73
1 month 160.93
Extreme 160.93
200.5
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer 63 31/12/2020
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Change 5d. change 1-year change 3-years change Capi.($)
-1.60%-5.40%-15.21%-28.66% 115B
-2.20%-5.73%+8.25%-16.30% 163B
-1.62%-6.43%-24.84%+36.71% 149B
-1.62%-2.32%-49.76%-1.86% 78.3B
+0.05%+1.78%+5.85%-8.48% 46.86B
-2.08%-0.71%-31.63%-39.05% 43.31B
-1.20%-7.30%-6.37%+20.46% 32.32B
-1.38%-3.39%-0.62%-12.73% 31.57B
-0.29%-2.36%-18.79%-13.17% 29.28B
-0.54%-6.00%-29.84%-48.26% 28.5B
Average -1.25%-4.24%-16.29%-11.13% 71.68B
Weighted average by Cap. -1.54%-4.89%-14.96%-5.86%

Financials

2026 *2027 *
Net sales 25.47B 21.92B 20.04B 19.12B 35.05B 2,444B 35.63B 240B 93.03B 1,160B 95.59B 93.54B 4,042B 26.99B 23.23B 21.24B 20.26B 37.14B 2,590B 37.76B 255B 98.59B 1,229B 101B 99.12B 4,283B
Net income 4.54B 3.9B 3.57B 3.4B 6.24B 435B 6.34B 42.81B 16.56B 207B 17.02B 16.65B 720B 5.75B 4.95B 4.53B 4.32B 7.92B 552B 8.05B 54.3B 21.01B 262B 21.59B 21.12B 913B
Net Debt 9.02B 7.76B 7.1B 6.77B 12.42B 866B 12.62B 85.18B 32.96B 411B 33.86B 33.14B 1,432B 4.92B 4.24B 3.87B 3.7B 6.78B 472B 6.89B 46.49B 17.99B 224B 18.48B 18.09B 781B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
15/05/26 161.91 $ -1.60% 4,053,983
14/05/26 164.54 $ -0.87% 4,209,038
13/05/26 165.99 $ -0.16% 6,527,021
12/05/26 166.26 $ -0.16% 5,417,225
11/05/26 166.52 $ -2.71% 7,378,509
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
161.91USD
Average target price
247.83USD
Spread / Average Target
+53.06%

Quarterly revenue - Rate of surprise